FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)
Article in Nuklearmedizin - NuclearMedicine (April 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
[18F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy
Article in European Journal of Nuclear Medicine and Molecular Imaging (March 2024)
Role of FDG PET/CT in Patients With Lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts.
Article in American Journal of Roentgenology (December 2023)